Why the study?
What is the role of endomyocardial biopsy in the management of cardiovascular disease?
What is the role of endomyocardial biopsy in the management of cardiovascular disease?
This document provides a joint scientific statement from the AHA, ACC, and ESC on the clinical indications for endomyocardial biopsy in cardiovascular disease management.
Answers are grounded in this paper and cite their sources.
Informs selective endomyocardial biopsy use in practice; extends prior guidance with updated AHA/ACC/ESC consensus.
May we draw your attention to the ESC/AHA/ACC scientific statement published in the December issue of the European Heart Journal .1 Scenario 10 discusses the indication for endomyocardial biopsy in patients with suspected myocardial siderosis (due to hereditary or acquired haemochromatosis). This states that ‘cardiac involvement …
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2008) studied this question. Endomyocardial biopsy is indicated to evaluate cardiac involvement in patients with suspected myocardial siderosis caused by hereditary or acquired haemochromatosis.
Synapse has enriched 10 related papers. Consider them for comparative context: